A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells
- PMID: 10698522
- DOI: 10.1038/sj.onc.1203337
A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells
Abstract
The Raf/MEK/MAP kinase cascade plays a critical role in transducing growth signals from activated cell surface receptors. Using deltaMEK1:ER, a conditionally-active form of MEK1, we demonstrate the ability of this dual specificity protein kinase to abrogate the cytokine-dependency of the human and murine hematopoietic cells lines TF-1, FDC-P1 and FL5.12. Cytokine-independent cells were obtained from TF-1, FDC-P1 and FL5.12 cells at frequencies of 2.5 x 10(-3), 5 x 10(-5) and 10(-7) respectively, indicating that not all cells expressing deltaMEK1:ER were factor-independent. In general, cells that were converted to a cytokine-independent phenotype displayed a higher level of MAP kinase activity in response to deltaMEK1:ER activation than those that remained cytokine-dependent. deltaME-K1:ER-responsive cells could be maintained long-term in the presence of beta-estradiol as well as the estrogen-receptor antagonist 4-Hydroxy-Tamoxifen and the anti-estrogen ICI 164383. Removal of hormone led to the rapid cessation of cell growth in a manner similar to that observed when cytokine is withdrawn from the parental cells. Treatment of deltaMEKI:ER-responsive cells with a specific and selective inhibitor, PD98059, prevented growth in response to beta-estradiol. GM-CSF mRNA transcripts were detected in the MEK1-responsive cells indicating that the activated deltaMEK1:ER may induce a pathway leading to autocrine proliferation. Treatment of MEK1-responsive cells with an anti-GM-CSF antibody, but not a control antibody, suppressed cell growth. The cell lines described here will be useful for elaborating the ability of the MAP kinase pathway to regulate cell proliferation in hematopoietic cells.
Similar articles
-
Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells.Leukemia. 2001 May;15(5):794-807. doi: 10.1038/sj.leu.2402109. Leukemia. 2001. PMID: 11368441
-
Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.Leukemia. 2000 Apr;14(4):642-56. doi: 10.1038/sj.leu.2401720. Leukemia. 2000. PMID: 10764150
-
Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells.Leukemia. 2000 Jun;14(6):1080-96. doi: 10.1038/sj.leu.2401793. Leukemia. 2000. PMID: 10865974
-
Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.Leukemia. 2003 Jun;17(6):1058-67. doi: 10.1038/sj.leu.2402925. Leukemia. 2003. PMID: 12764369
-
Cytokine regulation of apoptosis in hematopoietic precursor cells.Curr Opin Hematol. 1996 May;3(3):191-6. doi: 10.1097/00062752-199603030-00005. Curr Opin Hematol. 1996. PMID: 9372075 Review.
Cited by
-
Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development.Immunol Res. 2011 Apr;49(1-3):248-68. doi: 10.1007/s12026-010-8187-5. Immunol Res. 2011. PMID: 21170740 Review.
-
Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.J Clin Invest. 2001 Sep;108(6):851-9. doi: 10.1172/JCI12807. J Clin Invest. 2001. PMID: 11560954 Free PMC article.
-
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence.Cell Death Dis. 2014 Feb 27;5(2):e1089. doi: 10.1038/cddis.2014.63. Cell Death Dis. 2014. PMID: 24577087 Free PMC article.
-
Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.Adv Enzyme Regul. 2008;48:98-112. doi: 10.1016/j.advenzreg.2007.11.002. Epub 2007 Nov 19. Adv Enzyme Regul. 2008. PMID: 18155170 Free PMC article. Review. No abstract available.
-
A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation.Mol Cell Biol. 2003 Mar;23(6):1983-93. doi: 10.1128/MCB.23.6.1983-1993.2003. Mol Cell Biol. 2003. PMID: 12612072 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous